DOCSLIB.ORG

Method for Stabilization of Reduced Coenzyme Q10 Verfahren Zur Stabilisierung Von Reduziertem Coenzym Q10 Procédé Servant À Stabiliser Un Coenzyme Q10 Réduit

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Method for Stabilization of Reduced Coenzyme Q10 Verfahren Zur Stabilisierung Von Reduziertem Coenzym Q10 Procédé Servant À Stabiliser Un Coenzyme Q10 Réduit (19) TZZ Z_ __T (11) EP 2 017 251 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07C 41/46 (2006.01) A61K 8/35 (2006.01) 19.07.2017 Bulletin 2017/29 A61K 9/48 (2006.01) A61K 9/50 (2006.01) A61K 31/122 (2006.01) A61P 3/02 (2006.01) (2006.01) (2006.01) (21) Application number: 07742687.2 C07C 41/26 C07C 41/34 C07C 43/23 (2006.01) (22) Date of filing: 27.04.2007 (86) International application number: PCT/JP2007/059252 (87) International publication number: WO 2007/126083 (08.11.2007 Gazette 2007/45) (54) METHOD FOR STABILIZATION OF REDUCED COENZYME Q10 VERFAHREN ZUR STABILISIERUNG VON REDUZIERTEM COENZYM Q10 PROCÉDÉ SERVANT À STABILISER UN COENZYME Q10 RÉDUIT (84) Designated Contracting States: (74) Representative: Hoffmann Eitle AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Patent- und Rechtsanwälte PartmbB HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE Arabellastraße 30 SI SK TR 81925 München (DE) (30) Priority: 28.04.2006 JP 2006126897 (56) References cited: EP-A1- 1 415 970 EP-A1- 1 452 174 (43) Date of publication of application: WO-A1-03/032967 21.01.2009 Bulletin 2009/04 • MATSURA T. ET AL.: ’Antioxidant role of cellular (73) Proprietor: KANEKA CORPORATION reduced coenzyme Q homologs and Osaka (JP) alpha-tocopherol in free radical-induced injury of hepatocytes isolated from rats fed diets with (72) Inventors: different vitamin E contents’ BIOCHIMICA ET • UEDA, Takahiro BIOPHYSICA ACTA vol. 1127, 1992, pages 277 - Kobe-shi, Hyogo 655-0872 (JP) 283, XP003018946 • KITAMURA, Shiro Akashi-shi, Hyogo 673-0882 (JP) Remarks: • KUBO, Hiroshi Thefile contains technical information submitted after Kobe-shi, Hyogo 655-0046 (JP) the application was filed and not included in this • HOSOE, Kazunori specification Takasago-shi, Hyogo 676-0025 (JP) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 2 017 251 B1 Printed by Jouve, 75001 PARIS (FR) EP 2 017 251 B1 Description Technical Field 5 [0001] The present invention relates to a method of stabilizing reduced coenzyme 10Q, and a reduced coenzyme Q10-containing composition stable against oxidation. As compared to oxidized coenzyme Q 10, reduced coenzyme Q10 shows high oral absorbability, and is a compound useful as a superior food, food with nutrient function claims, food for specified health use, nutritional product, nutritional supplement, animal drug, drink, feed, pet food, cosmetic, pharma- ceutical product, therapeutic drug, prophylactic drug and the like. 10 Background Art [0002] It is known that reduced coenzyme Q10 can be obtained, for example, by a method comprising producing coenzyme Q10 by a conventionally known method such as synthesis, fermentation, extraction from a naturally occurring 15 substance and the like, and concentrating a reduced coenzyme Q 10 fraction in an eluate from chromatography and the like (patent reference 1). The patent reference 1 describes that, in this case, oxidized coenzyme Q10 contained in the above-mentioned reduced coenzyme Q10 may be reduced with a general reducing agent such as sodium borohydride, sodium dithionite (sodium hydrosulfite) and the like, and concentrated by chromatography, and that the reduced coen- zyme Q10 can also be obtained by a method comprising reacting existing highly pure coenzyme Q10 with the above- 20 mentioned reducing agent. [0003] In addition, production methods for conveniently obtaining reduced coenzyme Q10 are also disclosed (e.g., patent references 2 - 4). [0004] However, reduced coenzyme Q10 is easily oxidized by molecular oxygen into oxidized coenzyme Q10, and therefore, stabilization of reduced coenzyme Q 10 is an important issue when it is processed into a food, food with nutrient 25 function claims, food for specified health use, nutritional product, nutritional supplement, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like, or a material or composition therefor, or preserved after processing and the like. Complete removal or blocking of oxygen during the above-mentioned processing and preservation is extremely difficult, and remaining or admixed oxygen particularly during heating for processing and long-term preservation exerts a markedly adverse effect. The above-mentioned oxidation is directly 30 related to quality problems such as the by-product oxidized coenzyme Q10. [0005] As mentioned above, stabilization of reduced coenzyme Q10 (protection of oxidation) is a highly important object. However, since reduced coenzyme Q10 is not commercially available to date, the study of methods and compo- sitions for stable retention of reduced coenzyme Q10 has not been undertaken very much. [0006] As a conventionally-known method for stably retaining reduced coenzyme Q 10, a method including addition of 35 a reducing agent is known. However, some of the reducing agents used therefor are not suitable for food and pharma- ceutical agents. For example, patent reference 5 disclosing a composition concurrently containing a reducing agent and a production method thereof also discloses, (1) a composition comprising reduced coenzyme Q 10; a reducing agent in an amount effective for eliminating oxidation of reduced coenzyme Q 10 into oxidized coenzyme Q10; a surfactant, veg- etable oil or a mixture thereof in an amount effective for dissolving the above-mentioned reduced coenzyme Q10 and 40 the above-mentioned reducing agent; and a solvent as necessary, (2) a composition for oral administration wherein the above-mentioned composition is prepared into a gelatin capsule or a tablet, and (3) a method of preparing the above- mentioned composition containing reduced coenzyme Q10 in situ using oxidized coenzyme Q10 and a reducing agent. However, no detailed description relating to the quality, stabilizing effect and the like of the reduced coenzyme10 Q contained in the composition is provided, and the expected level of stabilization is not clear. 45 [0007] In addition, the above-mentioned composition and preparation method thereof are highly complicated and complex since plural roles are conferred to the composition (i.e., firstly, a role as a reaction site for reducing oxidized coenzyme Q10 to reduced coenzyme Q10, and secondly, a role of stably retaining reduced coenzyme Q10). Moreover, the above-mentioned composition and a preparation method thereof are not entirely safe because the reaction mixture is used as it is. In other words, ascorbic acids to be used as reducing agents are oxidized to produce a considerable 50 amount of dehydroascorbic acids, and the dehydroascorbic acids get mixed in with the above-mentioned composition, posing a problem. Dehydroascorbic acids and oxalic acid produced by decomposition from dehydroascorbic acids are highly noxious, unlike ascorbic acids. For example, an increased amount of lipid peroxide, a decreased amount of antioxidants in the liver and kidney and an increased amount of oxalic acid in the kidney have been reported, and side effects such as decreased resistance to oxidation stress, easy onset of ureteral lithiasis (non-patent reference 1) and 55 the like are feared. patent reference 1: JP-A-10-109933 patent reference 2: WO03/06408 2 EP 2 017 251 B1 patent reference 3: WO03/06409 patent reference 4: WO03/32967 patent reference 5: WO01/52822 non-patent reference 1: Nutrition Research Vol. 13, page 667-676, 1993 5 Disclosure of the Invention Problems to be Solved by the Invention 10 [0008] In view of the above, the present invention aims at providing a convenient and preferable method and a com- position for stably retaining reduced coenzyme Q 10 by protection against oxidation while maintaining high safety, during processing into a food, food with nutrient function claims, food for specified health use, nutritional product, nutritional supplement, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug containing reduced coenzyme Q 10 and the like, or a material or composition therefore, and/or preservation after process- 15 ing and the like. Means of Solving the Problems [0009] The present inventors have conducted intensive studies in an attempt to solve the above-mentioned problems 20 and found that reduced coenzyme Q10 can be stabilized by the co-presence of reduced coenzyme Q9 and/or reduced coenzyme Q11, which are analogs of reduced coenzyme Q 10 and reduced coenzyme Q10. [0010] That is, they have found that reduced coenzyme Q 10 can be stably retained by protecting the reduced coenzyme Q10 from oxidation by the co-presence of reduced coenzyme Q 9 (not less than 1.5 wt% to not more than 99 wt% relative to reduced coenzyme Q10) and/or reduced coenzyme Q11, even when a reducing agent is not used as a necessary 25 component to be added, which resulted in the completion of the present invention. [0011] Accordingly, the present invention provides the following. [1] A method for stabilizing reduced coenzyme Q 10, comprising achieving the co-presence of the reduced coenzyme Q10 any the following (a) and/or (b): 30 (a) not less than 1.5 wt% to not more than 99 wt% of reduced coenzyme Q 9 relative to the reduced coenzyme Q10, and/or (b) reduced coenzyme Q11. 35 [2] The method of [1] , wherein the aforementioned (a) reduced coenzyme Q9 and (b) reduced coenzyme Q11 are separately prepared and added. [3] The method of [1], wherein the co-presence is achieved by reducing the oxidized coenzyme 10Q comprising oxidized coenzyme Q9 and/or oxidized coenzyme Q11.
Load more

Recommended publications
  • Improved Procedure for the Reductive Acetylation of Acyclic Esters and a New Synthesis of Ethers
    J. Org. Chem. 2000, 65, 191-198 191 Improved Procedure for the Reductive Acetylation of Acyclic Esters and a New Synthesis of Ethers David J. Kopecky and Scott D. Rychnovsky* Department of Chemistry, University of California, Irvine, California 92717-2025 Received September 14, 1999 An optimized protocol for the DIBALH reductive acetylation of acyclic esters and diesters is described. This reductive acetylation procedure allows a wide variety of esters to be converted into the corresponding R-acetoxy ethers in good to excellent yields. It was found that, under mild acidic conditions, many R-acetoxy ethers can be further reduced to the corresponding ethers. This net two-step ester deoxygenation is an attractive alternative to the classical Williamson synthesis for certain ethers. Introduction The reduction and in situ acetylation of esters was developed in our laboratory several years ago to provide access to unusual cyclic acetal structures.1 The general strategy involved trapping of the aluminum hemiacetal intermediate found in the reduction of an ester to an aldehyde by diisobutylaluminum hydride (DIBALH). Other groups had previously trapped the same type of intermediate with a trimethylsilyl group.2 After some exploration, we found that acetic anhydride, DMAP, and pyridine led to efficient trapping to give R-acetoxy ethers 1 Figure 1. Original DIBALH reductive acetylation conditions from the cyclic esters we had been studying. We were for lactones and some acyclic esters. surprised to find that the same conditions gave satisfac- R tory yields of the -acetoxy ethers from acyclic esters. a 12 h period, an R-acetoxy ether of the general structure The R-acetoxy ethers can be activated with a variety of 3 was isolated.
    [Show full text]
  • Catalytic Effect of Ultrananocrystalline Fe3o4 on Algal Bio-Crude Production Via HTL Process
    Electronic Supplementary Material (ESI) for Nanoscale. This journal is © The Royal Society of Chemistry 2015 Catalytic Effect of Ultrananocrystalline Fe3O4 on Algal Bio-Crude Production via HTL Process Arnulfo Rojas-Péreza, Daysi Diaz-Diestraa,b, Cecilia B. Frias-Floresa, Juan Beltran-Huaraca,b, K. C. Dasc, Brad R. Weinera,b, Gerardo Morella,b and Liz M. Díaz-Vázquez*a Table 1-S: Profile of volatile and semivolatile compounds of the bio-crudes obtained from raw Ulva fasciata in absence of UNCFO (only compounds with quality identification factor higher that 70 were considered through NIST library) Library/ID Area Benzenepropanoic acid 0.1005 1H-Pyrrole 0.0114 Anthracene 0.0409 2,3,4-Trimethylpyrrole 0.0231 2,5-di-tert-Butyl-1,4-benzoquinone 0.0565 1H-Pyrrole 0.0493 Methylhydroquinon 0.1455 Pyridine 0.084 Acetophenone 0.0671 2-Pyridinamine, 4,6-dimethyl- 0.0094 Acetamide 0.08 2-Acetonylcyclopentanone 0.0097 1H-Indole, 2,6-dimethyl- 0.2334 Phenol 0.0503 1,2-Benzenediol 0.1657 Benzoic acid 0.09 Butylated Hydroxytoluene 0.2888 Benzenamine 0.0154 2-Isopropyl-10-methylphenanthrene 0.1123 2-Cyclopenten-1-one 0.147 5-Chloro-3-phenyl-1H-indazole 0.0976 2,4-Heptadiene 0.1024 1-Isopropyl-1H-indole 0.1426 Nonanoic acid 0.0385 Anthracene 0.067 7-Methylindan-1-one 0.0168 2,5-Diphenyl-2,4-hexadiene 0.0685 3-Methylcatechol 0.1156 2,3,7-Trimethylindole 0.2276 Acetophenone 0.1829 2-Methyl-5-(hexyn-1-yl)pyridine 0.0527 1H-Indole 0.1785 1-Nonadecene 0.2075 Acetamide, 0.1709 Heptadecanoic acid 0.2635 2,4-Diamino-N,N,5-trimethyl-6- 0.2219 9-Octadecenoic acid
    [Show full text]
  • University of Illinois
    UNIVERSITY OF ILLINOIS THIS IS TO CERTIFY THAT THE THESIS PREPARED UNDER MY SUPERVISION BY ENTITLED IS APPROVED BY ME AS FULFILLING THIS PART OF THE REQUIREMENTS FOR THE DEGREE OF. A pproved: *:'X T ‘ AD OF DEPARTMENT OF. O 1364 The Synthesis of Deuterium Labelled Precursors for Their Use in Mechanistic Studies of Chemical Vapor Deposition By Michael E. Smith Thesis for the Degree of Bachelor of Science in Chemistry College of Liberal Arts and Sciences University of Illinois Urbana, Illinois 1988 ACKNOWLEDGEMENTS This thesis is the culmination of three semesters of work in the Girolami group* I'd like to thank all of the members of the group for being supportive and always being there to answer my questions. I would especially like to thank the follwingt Jim Jensen for being a terrific source of advice and giving an undergraduate the chance to shoulder the load and do some real chemistry? Debbie Pollina for doing the groundwork for the chloride synthesis and pulling the magical Vielsmier reagent out of thin air (well, almost); Hans Gozum for teaching me the finer art of destructive chemistry and helping me get rid of my Austrian accent; and Dave Dempsey for making my excursions to 350B the stuff that legends are made of. Finally, my deepest thanks to Greg Girolami, who showed me what chemistry is all about, and helped put my feet firmly on the road to graduate school. TABLE OF CONTENTS Page Number Introduction 1 Results and Discussion 4 Experimental 10 Appendix* Use of AutoCAD Introduction 12 Menus 12 Display Capabilities 14 Drawing Modes 17 Editing 19 Hardcopy 20 Design Techniques 21 Conclusion 23 References 24 1 INTRODUCTION The synthesis of inorganic materials has traditionally involved high temperatures.
    [Show full text]
  • Observation of Water Dangling OH Bonds Around Dissolved Nonpolar Groups
    Observation of water dangling OH bonds around dissolved nonpolar groups P. N. Pereraa, K. R. Fegaa, C. Lawrenceb, E. J. Sundstroma, J. Tomlinson-Phillipsa, and Dor Ben-Amotza,1 aDepartment of Chemistry, Purdue University, West Lafayette, IN 47907; and bDepartment of Chemistry, Grand Valley State University, Allendale, MI 49401 Edited by Michael D. Fayer, Stanford University, Stanford, CA, and approved June 12, 2009 (received for review April 3, 2009) We report the experimental observation of water dangling OH spectra (20), and here, we employ it to uncover dangling OH bonds in the hydration shells around dissolved nonpolar (hydro- vibrational bands arising from the hydration shells around dissolved carbon) groups. The results are obtained by combining vibrational nonpolar groups. (Raman) spectroscopy and multivariate curve resolution (MCR), to The remainder of this article begins by describing the results reveal a high-frequency OH stretch peak arising from the hydration of the experiments we performed to confirm our assignment of shell around nonpolar (hydrocarbon) solute groups. The frequency the observed peak to water dangling OH bonds. Changes in the and width of the observed peak is similar to that of dangling OH intensity of the dangling OH peak are then used to estimate the bonds previously detected at macroscopic air–water and oil–water number of water dangling OH bonds around hydrocarbon chains interfaces. The area of the observed peak is used to quantify the of different size. The width of the observed dangling OH peak number of water dangling bonds around hydrocarbon chains of is used to establish a lower bound on the lifetime of the different length.
    [Show full text]
  • 215 F12-Notes-Ch 13
    Chem 215 F12-Notes – Dr. Masato Koreeda - Page 1 of 13 Date: September 10, 2012 Chapter 13. Alcohols, Diols, and Ethers Overview: Chemistry and reactions of sp3 oxygen groups, particularly oxidation of an alcohol, ether formation, and reactions of oxirane (epoxide) groups. I. What are alcohols, phenols, and ethers? IUPAC names Common names Alcohols (R-OH) Primary alcohols CH3OH methanol methyl alcohol (1°-alcohols) CH3CH2OH ethanol ethyl alcohol pKa ~16-17 CH3CH2CH2OH 1-propanol n-propyl alcohol H3C C CH2OH 2-methyl-1-propanol isobutyl alcohol H3C H H3C C CH2OH 2,2-dimethyl-1-propanol neopentyl alcohol H3C CH3 H C Secondary alcohols 3 C OH 2-propanol isopropyl alcohol (2°-alcohols) H3C H pKa ~17-18 H C-CH 3 2 C OH 2-butanol sec-butyl alcohol H3C H Tertiary alcohols H3C C OH 2-methyl-2-propanol tert-butyl alcohol (3°-alcohols) H3C CH pKa ~19 3 Phenols (Ph-OH) pKa ~10-12 diethyl ether Ethers (R-O-R') CH3CH2-O-CH2CH3 Ph-O-CH=CH2 phenyl vinyl ether RO-: alkoxy CH3O methoxy CH3CH2O ethoxy ArO-: aryloxy PhO phenoxy II. Oxidation Oxidation – historical use of the term: (1) oxide (oxyd/oxyde) – the ‘acid’ form of an element; e.g., S + air → oxide of S (acid of sulfur) (2) oxidation or oxidize – to make such an acid, to make the oxide (3) oxygen – Lavoisier: substance in the air that makes acids; “the bringer of acids” = “oxygen” (4) oxidation or oxidize – to increase the % oxygen in a substance (reduction: to reduce the % oxygen) More modern definition: oxidation or oxidize – loss of electrons (coupled with reduction as gain of electrons) Note: The loss of electrons (oxidation) by one atom or compound must be matched by the gain of electrons (reduction) by another.
    [Show full text]
  • Stereoselective Reduction of the Keto Group at 7-Position of a Bile Keto Acid
    Europaisches Patentamt J European Patent Office © Publication number: 0 230 085 Office europeen des brevets A1 © EUROPEAN PATENT APPLICATION <2j) Application number: 86202393.4S93.4 © Int. CI.4: C07J 9/00 @ Date of filing: 30.12.86 © Priority: 09.01.86 IT 1903886 © Applicant: BLASCHIM S.p.A. Via Vittor Pisani, 28 @ Date of publication of application: 1-20124 Milano(IT) 29.07.87 Bulletin 87/31 @ Inventor: Magni, Ambrogio © Designated Contracting States: Via Donizetti, 20 AT BE CH DE ES FR GB GR IT LI LU NL SE I-22058 Osnago Como(IT) Inventor: Piccolo, Oreste Via Cassa di Risparmi, 31 1-57100 Livorno(IT) Inventor: Ascheri, Antonio Via Don Sturzo, 4 I-20057 Vedano Al Lambro Mi(IT) © Representative: Marchi, Massimo et al c/o Marchi & Mittler s.r.l. Viaie Lombardia 20 1-20131 Milano(IT) © Stereoselective reduction of the keto group at 7-position of a bile keto acid. © The keto group at 7-position of a bile keto acid is stereoselectively reduced to beta-hydroxy group with hydrogen in the presence of nickel, of a base the quantity of which is of at least 0.3 mole to each mole of keto acid, and of an alcohol, having from 3 to 10 C atoms, selected from the group consisting of secondary alcohols, tertiary alcohols and beta-branched alcohols. 00 CM LU <erox Copy Centre 0 230 085 S. I tKtUSbLfcUTIVE REDUCTION OF THE KETO GROUP AT "-POSITION OF A BILE KETO ACID" i nis invention relates to a process tor reducing stereoselectiveiy the keto group at 7-position of a bile keto acid to beta hydroxy group with hydrogen in the presence of nickel, of a base the quantity of which is of at least 0.3 mole to each mole of keto acid, and of an alcohol, having from 3 to 10 C atoms, selected from the group consisting of secondary alcohols, tertiary alcohols and beta-branched alcohols.
    [Show full text]
  • Calculation of the Isobaric Heat Capacities of the Liquid and Solid Phase of Organic Compounds at and Around 298.15 K Based on Their “True” Molecular Volume
    molecules Article Calculation of the Isobaric Heat Capacities of the Liquid and Solid Phase of Organic Compounds at and around 298.15 K Based on Their “True” Molecular Volume Rudolf Naef Department of Chemistry, University of Basel, 4003 Basel, Switzerland; [email protected]; Tel.: +41-61-9119273 Received: 28 March 2019; Accepted: 20 April 2019; Published: 24 April 2019 Abstract: A universally applicable method for the prediction of the isobaric heat capacities of the liquid and solid phase of molecules at 298.15 K is presented, derived from their “true” volume. The molecules’ “true” volume in A3 is calculated on the basis of their geometry-optimized structure and the Van-der-Waals radii of their constituting atoms by means of a fast numerical algorithm. Good linear correlations of the “true” volume of a large number of compounds encompassing all classes and sizes with their experimental liquid and solid heat capacities over a large range have been found, although noticeably distorted by intermolecular hydrogen-bond effects. To account for these effects, the total amount of 1303 compounds with known experimental liquid heat capacities has been subdivided into three subsets consisting of 1102 hydroxy-group-free compounds, 164 monoalcohols/monoacids, and 36 polyalcohols/polyacids. The standard deviations for Cp(liq,298) were 20.7 J/mol/K for the OH-free compunds, 22.91 J/mol/K for the monoalcohols/monoacids and 16.03 J/mol/K for the polyols/polyacids. Analogously, 797 compounds with known solid heat capacities have been separated into a subset of 555 OH-free compounds, 123 monoalcohols/monoacids and 119 polyols/polyacids.
    [Show full text]
  • Supreme Court of the United States
    No. 19- In THE Supreme Court of tljr United Staten KANEKA CORPORATION, Petitioner, v. XIAMEN KINGDOMWAY GROUP COMPANY, PACIFIC RAINBOW INTERNATIONAL INC., Respondent. On Petition for Writ of Certiorari to the United States Court of Appeals for the Federal Circuit SUPPLEMENTAL APPENDIX Keith D. Nowak Counsel of Record William F. Sondericker Gerald W. Griffin Carter Ledyard & Milburn LLP Two Wall Street New York, New York 10005 (212) 732-3200 [email protected] Counsel for Petitioner fV/ED 291472 $ COUNSEL PRESS mlVSS& (800)274-3321 • (800)359-6859 I TABLE OF CONTENTS Page U.S. PATENT NO. 7,910,340 (’340 PATENT), WITH ATTACHED CERTIFICATE OF CORRECTION............................................ SA1 USPTO RESTRICTION REQUIREMENT & APPLICANT ELECTION IN RESPONSE TO RESTRICTION REQUIREMENT........................................................................ SA20 The Director of the United States Patent and Trademark Office Has received an applicationfor a patentfor a new and useful invention. The title and description of the invention, are enclosed. Qitiited The requirements of law have been com­ plied with, and it has been determined that a patent on the invention shall be granted States under the law. Therefore, this United States Patent Grants to the person(s) having title to this patent the right to exclude others from mak­ ing, using, offering for sale, or selling the invention throughout the United States of America or importing the invention into the United States ofAmerica, and if the invenr tion is a process, of the right to exclude oth­ ers from using, offering for sale or selling throughout the United States ofAmerica, or importing into the United States of America, products made by that process, for the term setforth in 35 U.S.C.
    [Show full text]
  • Aldrich Alcohols and Phenols
    Aldrich Alcohols and Phenols Library Listing – 1,200 spectra Subset of Aldrich FT-IR Library related to alcohols and phenols. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collection of FT-IR Spectra and the data has been carefully examined and processed by Thermo. The molecular formula, CAS (Chemical Abstracts Services) registry number, when known, and the location number of the printed spectrum in The Aldrich Library of FT-IR Spectra are available. Aldrich Alcohols and Phenols Index Compound Name Index Compound Name 306 ((1S)-ENDO)-(-)-BORNEOL, 99% 310 (1S,2S,3S,5R)-(+)- 1044 (+)-(4,6-O-BENZYLIDENE)METHYL- ISOPINOCAMPHEOL, 98% ALPHA-D- GLUCOPYRANOSIDE, 351 (2-ENDO, 3-EXO)-5-NORBORNENE- 97% 2,3- DIMETHANOL 1042 (+)-2,3-O-BENZYLIDENE-D- 355 (2-ENDO,3-EXO)- THREITOL, 99% BICYCLO(2.2.2)OCT-5-ENE- 2,3- 528 (+)-ARABINOGALACTAN DIMETHANOL, 96% 305 (+)-BORNEOL, 98% 1130 (2R,3R)-(+)-2-METHYL-3- 1198 (+)-CATECHIN HYDRATE, 98% PHENYLGLYCIDOL, 97% 284 (+)-CIS-P-MENTHANE-3,8-DIOL, 1166 (2R,3R)-(+)-3-(4- 97% BROMOPHENYL)GLYCIDOL, 97% 334 (+)-ISOPULEGOL, 99% 1128 (2R,3R)-(+)-3-PHENYLGLYCIDOL, 340 (+)-LIMONEN-10-OL, 95% 97% 330 (+)-P-MENTH-1-EN-9-OL, 97%, 121 (2R,3R)-(-)-2,3-BUTANEDIOL, 97% MIXTURE OF ISOMERS 129 (2R,4R)-(-)-PENTANEDIOL, 99% 445 (+)-PERSEITOL 122 (2S,3S)-(+)-2,3-BUTANEDIOL, 99% 332 (+)-TERPINEN-4-OL, 96% 1131 (2S,3S)-(-)-2-METHYL-3- 958 (+/-)-4-FLUORO-ALPHA-(N-
    [Show full text]
  • Facile Reduction of Carboxylic Acids by Zinc Borohydride
    5314 J. Org. Chem. 1995,60, 5314-5315 Notes Facile Reduction of Carboxylic Acids by Table 1. Rate and Stoichiometry of Reduction of Zinc Borohydride Carboxylic Acids with Zn(B&)Za mmol of H- consumedmmol of acid S. Narasimhan,* S. Madhavan, and acid K. Ganeshwar Prasad 0.25 h 0.5h 1.0 h 2.0h 3.0 h 4.0 h 5.0h 6.0h Centre for Agrochemical Research, SPIC Science benzoic 1.38 1.54 1.67 1.83 1.93 2.31 2.56 2.82 Foundation, Guindy, Madras 600 032, India benzoicb 1.38 1.54 1.76 1.86 2.02 2.34 2.63 3.10 palmitic 1.06 1.96 2.21 2.53 2.63 2.76 2.83 2.95 Received February 27, 1995 palmiticb 1.83 1.96 2.53 2.99 3.10 pivalic 2.15 2.40 2.84 2.92 It is well-known that basic borohydrides do not reduce pivalicb 2.15 2.41 2.82 2.92 carboxylic acids directly and invariably need addition of undecenoif gel other reagents' such as AlC13,2 12,3etc. to effect this Ratio of H- to acid, 8.25:2.5. Catalyzed by 10 mol % of transformation. However, zinc borohydride, which is cyclohexene. [H-]:[acid] = 1L2.5. considered to be a mild reagent,4 readily reduces both aliphatic and aromatic acids to the corresponding alcohols in refluxing THF. The reaction requires only stoichio- metric quantities of hydride for this conversion. RCH;!OB=O THF,67 "C 6 8RCOOH + 3Zn(BH4), 8RCHZOH + 8H2 Faster reduction of pivalic acid could be due to the The following representative acids were chosen for the bulky tert-butyl group.
    [Show full text]
  • Copyright by Andrew Robert Waldeck 2016
    Copyright by Andrew Robert Waldeck 2016 The Dissertation Committee for Andrew Robert Waldeck Certifies that this is the approved version of the following dissertation: Development and Application of Metal Catalyzed Transfer Hydrogenative C-C Bond Forming Reactions Committee: Michael J. Krische, Supervisor Stephen F. Martin Guangbin Dong Jennifer S. Brodbelt Sean M. Kerwin Development and Application of Metal Catalyzed Transfer Hydrogenative C-C Bond Forming Reactions by Andrew Robert Waldeck, B.S.; B.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin May 2016 Dedication To my parents and to Erin: Without your love and support, none of this would have been possible. Acknowledgements The work described in this document would not have been possible without the mentorship of Professor Krische and the collaboration of a number of talented individuals. Felix, Emma, Jeff, Anne-Marie, and Abbas: Working with each of you has made me a better chemist. Thank you for all of the help and guidance each of you has provided in the context of the projects on which we worked together. Thank you to rest of the Krische group for your insightful conversations. Victoria, Zach, and Stephen: Thank you for your help reviewing and editing this document and thank you for being a source of many laughs during my time here. John Ketcham: Thank you for your advice and insight regarding all things chemistry, but thank you especially for being a friend.
    [Show full text]
  • 215-216 HH W11-Notes-Ch 13
    Chem 215-216 HH W11-Notes – Dr. Masato Koreeda - Page 1 of 13 Date: February 9, 2011 Chapter 13. Alcohols, Diols, and Ethers Overview: Chemistry and reactions of sp3 oxygen groups, particularly oxidation of an alcohol, ether formation, and reactions of oxirane (epoxide) groups. I. What are alcohols, phenols, and ethers? IUPAC names Common names Alcohols (R-OH) Primary alcohols CH3OH methanol methyl alcohol (1°-alcohols) CH3CH2OH ethanol ethyl alcohol pKa ~16-17 CH3CH2CH2OH 1-propanol n-propyl alcohol H3C C CH2OH 2-methyl-1-propanol isobutyl alcohol H3C H H3C C CH2OH 2,2-dimethyl-1-propanol neopentyl alcohol H3C CH3 H C Secondary alcohols 3 C OH 2-propanol isopropyl alcohol (2°-alcohols) H3C H pKa ~17-18 H C-CH 3 2 C OH 2-butanol sec-butyl alcohol H3C H Tertiary alcohols H3C C OH 2-methyl-2-propanol tert-butyl alcohol (3°-alcohols) H3C CH pKa ~19 3 Phenols (Ph-OH) pKa ~10-12 diethyl ether Ethers (R-O-R') CH3CH2-O-CH2CH3 Ph-O-CH=CH2 phenyl vinyl ether RO-: alkoxy CH3O methoxy CH3CH2O ethoxy ArO-: aryloxy PhO phenoxy II. Oxidation Oxidation – historical use of the term: (1) oxide (oxyd/oxyde) – the ‘acid’ form of an element; e.g., S + air → oxide of S (acid of sulfur) (2) oxidation or oxidize – to make such an acid, to make the oxide (3) oxygen – Lavoisier: substance in the air that makes acids; “the bringer of acids” = “oxygen” (4) oxidation or oxidize – to increase the % oxygen in a substance (reduction: to reduce the % oxygen) More modern definition: oxidation or oxidize – loss of electrons (coupled with reduction as gain of electrons) Note: The loss of electrons (oxidation) by one atom or compound must be matched by the gain of electrons (reduction) by another.
    [Show full text]